on AFYREN (EPA:ALAFY)
AFYREN raises €23 million to develop its biorefinery
The greentech company AFYREN has completed a €23 million capital increase to optimize and expand its unique biorefinery, AFYREN NEOXY. This transaction was primarily subscribed to by Kemin Industries, with an investment of €20 million, and Bpifrance, through its Large Venture fund, investing €3 million. The issue price was set at €2.40 per share, representing a 9% premium over the volume-weighted average price.
The funds will be used to finance an industrial investment of around €20 million, aimed at increasing the plant's production capacity to 20 kilotons. Kemin Industries, a long-standing partner of AFYREN since 2018, sees this investment as a strategic opportunity in the European nutritional ingredients market.
The operation, officially announced on November 26, 2025, strengthens AFYREN's position as a leading European manufacturer in the field of bio-based molecules, while maintaining a sound financial structure.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all AFYREN news